Claudia R Kowalik1, Mariëlle M E Lakeman2, Sandra E Zwolsman3, Jan-Paul W R Roovers3. 1. Department of Obstetrics and Gynecology, Amsterdam University Medical Centre, Room H4-262, PO Box 22660, 1100, DD, Amsterdam, The Netherlands. c.r.kowalik@amsterdamumc.nl. 2. Department of Obstetrics and Gynecology, BovenIJ ziekenhuis, Statenjachtstraat 1, Po box 37610, 1030, BD, Amsterdam, The Netherlands. 3. Department of Obstetrics and Gynecology, Amsterdam University Medical Centre, Room H4-262, PO Box 22660, 1100, DD, Amsterdam, The Netherlands.
Abstract
INTRODUCTION AND HYPOTHESIS: Women with mesh-related complications in prolapse (POP) and stress-urinary incontinence (SUI) surgery may benefit from operative mesh resection to alleviate symptoms. We hypothesized that mesh resection would alleviate symptoms and aimed to evaluate risks and benefits in these women. METHODS: We carried out a cross-sectional study. Primary outcome was improvement specified as better, unchanged or worsened symptoms after mesh revision surgery. Secondary outcomes were health-related quality of life (HrQol) scores of validated questionnaires, surgical characteristics and physical findings at follow-up visits. Descriptive data were reported with mean and medians. Associations were calculated with Spearman correlation coefficient and chi-square test to determine statistical differences between groups. RESULTS: Fifty-nine women who underwent mesh revision surgery between 2009 and 2016 were included. After a median follow-up of 1.7 (IQR: 1.1-2.4) years, 44 women (75%) reported improvement of symptoms. No significant surgical or patient characteristics were identified that could differentiate which patients did or did not experience cure or complications.A trend was observed to better HrQol scores in women who reported overall improvement after mesh revision surgery. Seventeen (29%) women needed a subsequent operation after mesh removal. CONCLUSIONS: This cross-sectional study shows that mesh revision surgery alleviates symptoms in 75% of women with mesh-related complications. Type of revision surgery and individual characteristics did not seem to matter to the individual chance of cure or complications. These data can facilitate the counseling of women considering mesh revision surgery.
INTRODUCTION AND HYPOTHESIS: Women with mesh-related complications in prolapse (POP) and stress-urinary incontinence (SUI) surgery may benefit from operative mesh resection to alleviate symptoms. We hypothesized that mesh resection would alleviate symptoms and aimed to evaluate risks and benefits in these women. METHODS: We carried out a cross-sectional study. Primary outcome was improvement specified as better, unchanged or worsened symptoms after mesh revision surgery. Secondary outcomes were health-related quality of life (HrQol) scores of validated questionnaires, surgical characteristics and physical findings at follow-up visits. Descriptive data were reported with mean and medians. Associations were calculated with Spearman correlation coefficient and chi-square test to determine statistical differences between groups. RESULTS: Fifty-nine women who underwent mesh revision surgery between 2009 and 2016 were included. After a median follow-up of 1.7 (IQR: 1.1-2.4) years, 44 women (75%) reported improvement of symptoms. No significant surgical or patient characteristics were identified that could differentiate which patients did or did not experience cure or complications.A trend was observed to better HrQol scores in women who reported overall improvement after mesh revision surgery. Seventeen (29%) women needed a subsequent operation after mesh removal. CONCLUSIONS: This cross-sectional study shows that mesh revision surgery alleviates symptoms in 75% of women with mesh-related complications. Type of revision surgery and individual characteristics did not seem to matter to the individual chance of cure or complications. These data can facilitate the counseling of women considering mesh revision surgery.
Authors: H Jorien van Brummen; Hein W Bruinse; Geerte van de Pol; A Peter M Heintz; C Huub van der Vaart Journal: Int Urogynecol J Pelvic Floor Dysfunct Date: 2005-08-03
Authors: Sophie Warembourg; Majd Labaki; Renaud de Tayrac; Pierre Costa; Brigitte Fatton Journal: Int Urogynecol J Date: 2017-02-01 Impact factor: 2.894
Authors: Daniel Altman; Tapio Väyrynen; Marie Ellström Engh; Susanne Axelsen; Christian Falconer Journal: N Engl J Med Date: 2011-05-12 Impact factor: 91.245
Authors: Cathryn Ma Glazener; Suzanne Breeman; Andrew Elders; Christine Hemming; Kevin G Cooper; Robert M Freeman; Anthony Rb Smith; Fiona Reid; Suzanne Hagen; Isobel Montgomery; Mary Kilonzo; Dwayne Boyers; Alison McDonald; Gladys McPherson; Graeme MacLennan; John Norrie Journal: Lancet Date: 2016-12-21 Impact factor: 79.321
Authors: Mariëlla I Withagen; Alfredo L Milani; Jan den Boon; Harry A Vervest; Mark E Vierhout Journal: Obstet Gynecol Date: 2011-02 Impact factor: 7.661
Authors: Erin C Crosby; Melinda Abernethy; Mitchell B Berger; John O DeLancey; Dee E Fenner; Daniel M Morgan Journal: Obstet Gynecol Date: 2014-01 Impact factor: 7.661